Literature DB >> 19915596

Neonatal pharmacology: rational therapeutics for the most vulnerable.

L James, S Ito.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19915596      PMCID: PMC2929243          DOI: 10.1038/clpt.2009.212

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  15 in total

1.  Advancing women's health in the 21st century: applying the tools of clinical pharmacology.

Authors:  K Uhl
Journal:  Clin Pharmacol Ther       Date:  2008-01       Impact factor: 6.875

2.  Fluconazole prophylaxis against fungal colonization and infection in preterm infants.

Authors:  D Kaufman; R Boyle; K C Hazen; J T Patrie; M Robinson; L G Donowitz
Journal:  N Engl J Med       Date:  2001-12-06       Impact factor: 91.245

3.  Developmental pharmacogenetics: a general paradigm for application to neonatal pharmacology and toxicology.

Authors:  J S Leeder
Journal:  Clin Pharmacol Ther       Date:  2009-10-28       Impact factor: 6.875

4.  Population pharmacokinetics of fluconazole in young infants.

Authors:  K C Wade; D Wu; D A Kaufman; R M Ward; D K Benjamin; J E Sullivan; N Ramey; B Jayaraman; K Hoppu; P C Adamson; M R Gastonguay; J S Barrett
Journal:  Antimicrob Agents Chemother       Date:  2008-09-22       Impact factor: 5.191

5.  Prescription drug use in pregnancy.

Authors:  Susan E Andrade; Jerry H Gurwitz; Robert L Davis; K Arnold Chan; Jonathan A Finkelstein; Kris Fortman; Heather McPhillips; Marsha A Raebel; Douglas Roblin; David H Smith; Marianne Ulcickas Yood; Abraham N Morse; Richard Platt
Journal:  Am J Obstet Gynecol       Date:  2004-08       Impact factor: 8.661

6.  Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome.

Authors:  M S Mouksassi; J F Marier; J Cyran; A A Vinks
Journal:  Clin Pharmacol Ther       Date:  2009-10-21       Impact factor: 6.875

7.  Sustained neurobehavioral effects of exposure to SSRI antidepressants during development: molecular to clinical evidence.

Authors:  T F Oberlander; J A Gingrich; M S Ansorge
Journal:  Clin Pharmacol Ther       Date:  2009-11-04       Impact factor: 6.875

8.  Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat.

Authors:  Enrica Fornaro; Dongge Li; Jingyi Pan; Jaques Belik
Journal:  Am J Respir Crit Care Med       Date:  2007-08-16       Impact factor: 21.405

9.  Clinical trials in neonates: a therapeutic imperative.

Authors:  R M Ward; S E Kern
Journal:  Clin Pharmacol Ther       Date:  2009-12       Impact factor: 6.875

10.  Clinical trial design in neonatal pharmacology: effect of center differences, with lessons from the Pediatric Oncology Cooperative Research experience.

Authors:  C Moran; P B Smith; M Cohen-Wolkowiez; D K Benjamin
Journal:  Clin Pharmacol Ther       Date:  2009-12       Impact factor: 6.875

View more
  2 in total

1.  Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Authors:  Michael Rieder
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Jan-Feb

2.  Federal legislation and the advancement of neonatal drug studies.

Authors:  Jason R Wiles; Alexander A Vinks; Henry Akinbi
Journal:  J Pediatr       Date:  2012-10-27       Impact factor: 4.406

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.